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D. Nutzinger (Vienna) reported effects and 
problems encountered in combined drug and psychotherapy 
treatment. Most studies are based on an additive model 
tested by 2x2 designs, but only very few include a third 
group i. e. a placebo pill and placebo psychotherapy group as 
additional controls. Besides several other studies, a combined 
fluphenazine and behavior therapy study confirmed the as· 
sumption that medical treatment is superior to psychother· 
apy, however the combination of both is more effective than 
single treatment procedures. The discussion emphasized that 
uncontrollable factors like self·selection of patients and previ· 
ous exposure to psychotherapy are hard to control, but that 
in many patients additional medication is the only way to 
render extreme distress accessible to psychotherapy. 
The many difficulties encountered in the eval· 
uation of multicenter studies were demonstrated by H. Kat· 
schnig (Vienna) who reffered to the results of a cross national 
study with 12 collaborating centres comparing imipramine, 
alprazolam, and placebo. Data revealed that differences bet· 
ween centres and countries mainly referred to severity and 
type of panic attacks. This can be partially explained by lin· 
guistic discrepancies and cross cultural differences in the 
symptomatology of panic and anxiety. Dropout rates were 
found to differ considerably between centres; both active 
compounds turned out to be superior compared to placebo 
except for the United Kingdom, where no significant differ· 
ences between placebo and alprazolam were found. The dis· 
cu.ssion was concerned with problems of stratified or meta· 
analyses in multicenter studies and coping with heterogene· 
ities derived from differences in non·drug therapeutic factors 
(e. g. endeavour to keep patients in the study protocol). 
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Expressive behavior must be described in a 
threefold manner: first there is the ACTOGRAM of be· 
havior which includes the obvious meaning of an expression 
(the semantics). Second, all expressive behavior has topologi· 
cal consequences, i. e. variations in space - the TOPO· 
GRAM. Finally, behavior has a temporal structure - the 
CHRONOGRAM. This last describes the temporal features 
of behavior as well as clarifying the communicative meaning 
which the temporal structure of an expressive act has. 
Speaking as an expressive act can only occur 
sequentially, (whereas spatial relations exist simultaneously). 
Sounds must be produced one at a time, hence the com· 
munication between two persons must be organized in a 
'now me - then you' sequence. Therefore, the psychological 
processes which structure time can best be analyzed in 
Pharmacopsychiat. 25 (1992) 77 
speech. This is done by SPEECH CHRONEMICS, a discip· 
line which from a methodological viewpoint has to point out 
that time viewed psychologically is quite different from the 
time concept in physics. Psychological time as it is realized in 
the temporal structure of speaking must be understood as an 
ON·OFF pattern which is hierarchically ordered into four 
time levels: 
- the MACRO level which discriminates the ON·OFF of 
daily periods when conversations occur and when they do 
not. "Zooming" inside one conversation yields a new ON· 
OFF, the 
- the UPPER MESO LEVEL. ON·OFFs within one con· 
versation are utterances and the respective pauses. In a still 
more detailed look (in chronography this is done by a 
faster resolution of the signal) one utterance is 
- at the LOWER MESO LEVEL, a new ON·OFF en· 
semble of vocalizations and pauses between them (dura· 
tion: shorter than I second). Finally, a single vocalization is 
at the 
- MICRO level an ON·OFF pattern of phonations and 
articulation pauses (shorter than 200 milliseconds). 
The workshop dealt with the question of 
whether these different time levels have special validities in 
psychopharmacological research. All contributions used the 
same methodology: the analysis of the time structure of 
speech was done by the LOGOPORT, a device described in 
Kruger (Pharmacopsychiatry, 22 (1),19895-12). 
Hain & Maier (Mainz) assessed various 
speech parameters at the micro and me so level in a longitudi· 
nal investigation of 18 initially unmedicated patients with 
major depression and 8 healthy controls. On admission, pro· 
longed pause times during effortful counting ("count as fast 
as you can") discriminated best between the two groups. Sig· 
nificant correlations were found between the pause times and 
scores on the HAMD and Widlocher scale, notably the 
motor·retardation items. During successful antidepressant 
pharmacotherapy, the pause times above a cutoff level of 200 
ms (me so level) were shortened, whereas the pauses below 
this level (articulatory level) became slightly longer. In some 
cases the change of speech parameters came before the clini· 
cal improvement, indicating their predictive potential. Apart 
from their use for the evaluation of antidepressant therapy, 
speech recordings may be a valuable tool for the objective 
monitoring of the psychomotor state in other conditions such 
as negative schizophrenia. 
These results at the articulatory level agreed 
with those of Vollrath (Wiirzburg). It has long been under· 
stood that the pronounciation of a stop consonant in the 
context vowel·consonant (as in/ak/) yields an articulation 
pause (AP) caused by a brief closure of the oral cavity. 
Within the context consonant·vowel (as in/ka/) the voice· 
onset time (VOT) is observed which corresponds to the time 
needed to switch from the consonant to the vowel. Psycholin· 
guistic resaerch found only small variation between subjects 
in the duration of the AP and VOT when a certain stop 
consonant is produced in a stable prosodic environment. This 
stability is due to the fact that the duration of these para· 
meters is an important cue for the perception and the distinc· 
tion of different stop·consonants. Many speech disorders are 
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characterized by altered durations of the AP and VOT. 
Despite this clinical evidence, no systematic research has 
been done concerning the question whether variations in the 
duration of the AP or VOT are associated with different 
states of arousal. 
To investigate this hypothesis, Vollrath ob-
served the production of an AP and VOT under highly con-
trolled conditions. In a placebo-controlled study the duration 
of the AP decreased significantly under the influence of caf-
feine. However, there was no significant change in the VOT. 
A case study investigated these parameters under three dif-
ferent levels of blood alcohol concentration (BAC). The dura-
tion of the AP increased during the rise-time of the BAC and 
decreased when the peak of the BAC was passed. Without 
alcohol, there was no comparable trend. Again, there was no 
systematic effect on the VOT. These results are encouraging 
for the use of the AP as a new and sensitive methodological 
tool. However, further research has to be done to clarify the 
underlying psychophysiological processes. 
The use of chronemic parameters in the study 
of hyperactive children was demonstrated by Trott, Menzel, 
Bonerad & Friese (Wiirzburg). In judging the course of treat-
ment of hyperkinetic syndrome, psychiatrists have hitherto 
preferred rating scales to get a global activity evaluation at 
the behaviorallevel. In addition, objective psychometric tests 
were given under controlled conditions. This last have pro-
ven useless in the laboratory, as hyperkinetic children behave 
relatively normally in low-stimulus environments. The 
authors have used chronemic parameters to study the ther-
apeutic effectiveness of Moclobemid among 20 hyperkinetic 
children. Speech measurements were made with the LOGO-
PORT in situations of everyday life. The duration and the 
amount of speaking activity decreased, while the intervals 
between conversations grew longer. ACTOMETER readings 
on motor unrest showed a decrease in gross motor activity, 
especially in specifically disturbing situations such as school 
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lessons, but also during sleep. For evaluating fine motor ac-
tions with this group of patients standardized analyses in the 
laboratory have proven useful. 
A combination of measures for speaking and 
motor activity also was used by Kazenwadel, Dennler, Dunkl 
& Kohnen (Wiirzburg/Niirnberg). In a placebo-controlled, 
double-blind and randomized experiment, the authors investi-
gated the effects of Hydergin i. v. (10 ml) on motor and so-
cial activity of 80 geriatric outpatients. Patients received infu-
sion treatments 2 hours a day for 3 weeks. Synchronous 
measurements of speaking and motor activity were recorded 
in situations of everyday life with portable devices (LOGO-
PORT and ACTIGRAPH) on days 1, 11, and 22 of treat-
ment. A preliminary statistical analysis of the final measure-
ments on day 22 revealed no differences in motor activity, 
but higher social activity (i. e., more and longer conversa-
tions) in Hydergin-treated patients, compared to the placebo 
group. 
Bivariate analysis of both parameters indi-
cated that the observed changes in speaking activity are not 
caused by a general increase of motor activity. Under verum 
treatment, motor activity is reduced, if at all, only in "non-so-
cial" situations. Thus, the behavioral effects of Hydergin i. v. 
are more adequately interpreted in terms of emotional 
and/or cognitive effects. 
Conclusions: The contributions proved that 
the chronemic structure of behavior - especially the time 
pattern of speech - is a promising tool in the evaluation of 
drug effects. It was shown that, whereas micro processes 
mostly refer to psychomotoric changes, the meso and macro 
level may be used as indicators for cognitive and emotional 
effects. The parallel use of motor and verbal behavior-moni-
toring devices seems to be especially fruitful for the under-
standing of drug effects. 
